Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980340 · ClinicalTrials.gov registry record
Breath Biomarkers for Sleep Loss and Circadian Timing
A clinical trial, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03980340: Clinical Trial study, sponsored by Brigham and Women's Hospital.
NCT03980340 is a clinical trial that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03980340 was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Insufficient sleep has both health and safety risks, but currently there are no quick, accurate and inexpensive ways to measure sleep deficiency. The current study aims to use a cutting-edge technology, small molecule analysis (e.g. metabolomics), to detect compounds in breath that reliably change with sleep-wake state and those whose levels vary by time of day.
Primary Outcome
The change in composition of chemical analytes from the breath analysis tests will be compared between the Short Nap Intervention and No Nap Intervention groups to see if there is a sleep-related change in the components of breath.
Interventions
- BEHAVIORAL Short Nap Intervention
- BEHAVIORAL No Nap Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2025-03-31 |
Why NCT03980340 stopped before completion
NCT03980340 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Short Nap Intervention is the first listed.
NCT03980340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03980340 about?
NCT03980340 is a clinical study titled "Breath Biomarkers for Sleep Loss and Circadian Timing". Insufficient sleep has both health and safety risks, but currently there are no quick, accurate and inexpensive ways to measure sleep deficiency. The current study aims to use a cutting-edge technology, small molecule analysis (e.g. metabolomics), to detect compounds in breath that reliably change w...
What is the current status of trial NCT03980340?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2021-01-28. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03980340?
The interventions under investigation include: Short Nap Intervention (BEHAVIORAL), No Nap Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03980340?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI